ct

Recent in Claims/Labeling (page 8 of 8)

FDA Adds Cosmetic Manufacturers to Import Alert for Drug Claims

The US Food & Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has re-issued an import alert that scrutinizes cosmetic manufacturers importing antiaging products into the United States that make drug claims.

Comparatively Speaking: Cosmetic Labeling in the United States

In this excerpt, Tony O'Lenick looks to Perry Romanowski to explain how to list ingredients on a cosmetic product label in the United States, for the benefit of novice formulators.

Is Cosmetic Science Really "Bad"? Part V: Who do you think you are fooling?

In previous installments of this series, the author applied Michael Shermer's Baloney Detection Kit, which includes ten questions to ask to validate a science, to cosmetic science. Having previously applied the first eight questions, the author addresses the final two in this installment.

FDA Cracks Down on Medicinal Claims Regarding Bee By-products

The US Food and Drug Administration (FDA) cracked down on Wisconsin-based Beehive Botanicals Inc. after the company did not comply with requests to remove and change misbranded and unapproved claims from its Web site and labels.

Certifying Hair Product Claims

Claims for hair products generally are not associated with clear cut outcomes. Therefore, consumers have no standard by which to compare product efficacy. In relation, the North American Hair Research Society (NAHRS) has proposed standards for hair product claims, outlined here, which relate to characteristics including frizz, color fastness and curl retention, among others.

Translating Data into Claims and Interpreting Regulations: Science vs. Marketing

Substantial evidence, which the FDA requires to support claims for drugs, is applicable to personal care, especially considering the pharmaceutical direction products have taken. The present article considers whether the industry is benefiting from marketing without assuming the responsibility for potential effects. In addition, it considers the limitations of in vitro and in vivo test models.

Can't find what you're looking for? Try searching, or looking through past issues.